Skip to content
TNGX·Nasdaq·US

Tango Therapeutics

Tango Therapeutics is a clinical-stage precision oncology biotechnology company focused on discovering and developing novel cancer therapies. Its business model centers on a proprietary CRISPR-enabled discovery platform and on monetizing programs through collaboration, licensing, and development agreements.

Thematic Position

TNGX

Relationship Groups

Suppliers3
Partners4
Licensing1
Competitors8

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

4 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

price controlstate aidtariff
Inflation Reduction Act imposes Medicare drug price negotiation and rebate requirements on Tango Therapeutics
SEC 10-KMar 5, 2026

The full regulatory passage is part of the Pro plan.

10 more · Regulatory and geopolitical insights are part of the Pro plan.